Category: Markets
Published: 2026-06-22T15:00:00.000Z
Zealand Pharma completed 215,000 share repurchases during week 25 (June 15-19, 2026) at an average price of DKK 293.92 per share, totaling DKK 62.18 million. The company has now accumulated 1,224,000 shares under its DKK 1.3 billion buy-back program, representing approximately 2.93% of share capital. The program, managed by Danske Bank, is scheduled for completion by October 31, 2026.
News summary curated and translated by CausifyMarket. Always consult original sources before making any financial decision.